The Universal 3D QSAR Model for Dopamine D₂ Receptor Antagonists.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Discovering novel antipsychotics requires understanding dopamine D2 receptor antagonist structure-activity relationships.
• Existing knowledge gaps hinder the design of new drugs targeting the D2 receptor.

Purpose of the Study:

• To construct a universal 3D-QSAR model for competitive dopamine D2 receptor antagonists.
• To predict the activity of novel compounds and elucidate ligand-receptor interactions.

Main Methods:

• Utilized 176 compounds with IC50 data from the CHEMBL database.
• Performed molecular docking to the human D2 receptor X-ray structure.
• Applied Comparative Molecular Field Analysis (CoMFA) for model development and validation.

Main Results:

• Developed a significant CoMFA model (Q²=0.76, R²=0.92) with steric and electrostatic contributions.
• Successfully predicted IC50 values for a test set with high accuracy (R²=0.95).
• Identified potential bitopic binding interactions involving an allosteric pocket.

Conclusions:

• The validated CoMFA model accurately predicts dopamine D2 receptor antagonist activity.
• The findings suggest some antagonists may exhibit bitopic binding, interacting with both orthosteric and allosteric sites.
• The model serves as a valuable tool for designing novel antipsychotic drug candidates.